132 related articles for article (PubMed ID: 35995384)
1. Targeted proteomics using parallel reaction monitoring confirms salivary proteins indicative of metastatic triple-negative breast cancer.
Giri K; Maity S; Ambatipudi K
J Proteomics; 2022 Sep; 267():104701. PubMed ID: 35995384
[TBL] [Abstract][Full Text] [Related]
2. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
[TBL] [Abstract][Full Text] [Related]
3. Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9.
Muñiz Lino MA; Palacios-Rodríguez Y; Rodríguez-Cuevas S; Bautista-Piña V; Marchat LA; Ruíz-García E; Astudillo-de la Vega H; González-Santiago AE; Flores-Pérez A; Díaz-Chávez J; Carlos-Reyes Á; Álvarez-Sánchez E; López-Camarillo C
J Proteomics; 2014 Dec; 111():198-211. PubMed ID: 24768906
[TBL] [Abstract][Full Text] [Related]
4. Targeted Proteomics Guided by Label-free Quantitative Proteome Analysis in Saliva Reveal Transition Signatures from Health to Periodontal Disease.
Bostanci N; Selevsek N; Wolski W; Grossmann J; Bao K; Wahlander A; Trachsel C; Schlapbach R; Öztürk VÖ; Afacan B; Emingil G; Belibasakis GN
Mol Cell Proteomics; 2018 Jul; 17(7):1392-1409. PubMed ID: 29610270
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Pattern of hPTMs by Mass Spectrometry-Based Proteomics with Implications for Triple-Negative Breast Cancer.
Liu C; Xu M; Li W; Cao X; Wang Y; Chen H; Zhang T; Lu M; Xie H; Chen Y
J Proteome Res; 2024 Apr; 23(4):1495-1505. PubMed ID: 38576392
[TBL] [Abstract][Full Text] [Related]
6. Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.
Gámez-Pozo A; Trilla-Fuertes L; Prado-Vázquez G; Chiva C; López-Vacas R; Nanni P; Berges-Soria J; Grossmann J; Díaz-Almirón M; Ciruelos E; Sabidó E; Espinosa E; Fresno Vara JÁ
PLoS One; 2017; 12(6):e0178296. PubMed ID: 28594844
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancer.
Lin Y; Lin L; Fu F; Wang C; Hu A; Xie J; Jiang M; Wang Z; Yang L; Guo R; Yang P; Shen H
Breast Cancer Res Treat; 2021 Jan; 185(1):39-52. PubMed ID: 32920739
[TBL] [Abstract][Full Text] [Related]
8. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.
Li Y; Zhang Y; Zhou X; Xue X; Wang M; Kang D; Zhou Y; Hu R; Quan S; Xing G; Yang J
BMC Nephrol; 2023 Mar; 24(1):50. PubMed ID: 36894904
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the differences of serum protein mass spectrometry in patients with triple negative breast cancer and non-triple negative breast cancer.
Liu AN; Sun P; Liu JN; Yu CY; Qu HJ; Jiao AH; Zhang LM
Tumour Biol; 2014 Oct; 35(10):9751-7. PubMed ID: 24972967
[TBL] [Abstract][Full Text] [Related]
10. iTRAQ-based quantitative analysis of age-specific variations in salivary proteome of caries-susceptible individuals.
Wang K; Wang X; Zheng S; Niu Y; Zheng W; Qin X; Li Z; Luo J; Jiang W; Zhou X; Li W; Zhang L
J Transl Med; 2018 Oct; 16(1):293. PubMed ID: 30359274
[TBL] [Abstract][Full Text] [Related]
11. Comparative salivary proteomics analysis of children with and without dental caries using the iTRAQ/MRM approach.
Wang K; Wang Y; Wang X; Ren Q; Han S; Ding L; Li Z; Zhou X; Li W; Zhang L
J Transl Med; 2018 Jan; 16(1):11. PubMed ID: 29351798
[TBL] [Abstract][Full Text] [Related]
12. Proteomic identification of salivary biomarkers of type-2 diabetes.
Rao PV; Reddy AP; Lu X; Dasari S; Krishnaprasad A; Biggs E; Roberts CT; Nagalla SR
J Proteome Res; 2009 Jan; 8(1):239-45. PubMed ID: 19118452
[TBL] [Abstract][Full Text] [Related]
13. iTRAQ-Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple-Negative Breast Cancer Tumors.
Jézéquel P; Guette C; Lasla H; Gouraud W; Boissard A; Guérin-Charbonnel C; Campone M
Proteomics; 2019 Nov; 19(21-22):e1800484. PubMed ID: 30951236
[TBL] [Abstract][Full Text] [Related]
14. Technical considerations for large-scale parallel reaction monitoring analysis.
Gallien S; Bourmaud A; Kim SY; Domon B
J Proteomics; 2014 Apr; 100():147-59. PubMed ID: 24200835
[TBL] [Abstract][Full Text] [Related]
15. Variability Assessment of 90 Salivary Proteins in Intraday and Interday Samples from Healthy Donors by Multiple Reaction Monitoring-Mass Spectrometry.
Hsiao YC; Chu LJ; Chen YT; Chi LM; Chien KY; Chiang WF; Chang YT; Chen SF; Wang WS; Chuang YN; Lin SY; Chien CY; Chang KP; Chang YS; Yu JS
Proteomics Clin Appl; 2018 Mar; 12(2):. PubMed ID: 29350471
[TBL] [Abstract][Full Text] [Related]
16. Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits.
Giacomelli C; Jung J; Wachter A; Ibing S; Will R; Uhlmann S; Mannsperger H; Sahin Ö; Yarden Y; Beißbarth T; Korf U; Körner C; Wiemann S
BMC Cancer; 2021 Dec; 21(1):1296. PubMed ID: 34863149
[TBL] [Abstract][Full Text] [Related]
17. Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.
Quintero M; Adamoski D; Reis LMD; Ascenção CFR; Oliveira KRS; Gonçalves KA; Dias MM; Carazzolle MF; Dias SMG
BMC Cancer; 2017 Nov; 17(1):727. PubMed ID: 29115931
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Landscape of Exosomes Reveals the Functional Contributions of CD151 in Triple-Negative Breast Cancer.
Li S; Li X; Yang S; Pi H; Li Z; Yao P; Zhang Q; Wang Q; Shen P; Li X; Ji J
Mol Cell Proteomics; 2021; 20():100121. PubMed ID: 34265469
[TBL] [Abstract][Full Text] [Related]
19. Chronic exposure to multiple stressors alters the salivary proteome of piglets.
Prims S; Van Ostade X; Ayuso M; Dom M; Van Raemdonck G; Van Cruchten S; Casteleyn C; Van Ginneken C
PLoS One; 2023; 18(5):e0286455. PubMed ID: 37235602
[TBL] [Abstract][Full Text] [Related]
20. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation.
Velloso FJ; Campos AR; Sogayar MC; Correa RG
BMC Genomics; 2019 Feb; 20(1):152. PubMed ID: 30791886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]